Archives

by in
Entry Author Date Location
Marathon and Zafgen Add to Series B Rounds, Athenahealth and Sermo Announce Partnership, Sensata Sets IPO Terms, & More Boston-Area Deals News 03/03/10 Boston
Intrinsic Therapeutics Grabs $18M 02/26/10 Boston
Intrinsic Therapeutics Obtains $18,000,000 New Funding Round 02/26/10 Boston
San Diego’s Tioga Pharmaceuticals Raises $18 Million to Develop IBS Drug 02/17/10 San Diego
Tioga Pharmaceuticals Secures $18,000,000 New Funding Round 02/17/10 San Diego
Pearl Therapeutics Garners $15,000,000 Series C Round 02/01/10 San Francisco
Afferent Pharmaceuticals Receives $23,000,000 Series A Round 12/16/09 Boston
HubSpot Spots $16M, Synageva BioPharma Secures $12M, Currensee Sews Up $6M, & More Boston-Area Deals News 10/23/09 Boston
Flexion Pulls in $33M, Cubist Teams With Hydra, Charles River Makes Cuts, & More Boston-Area Life Sciences News 10/21/09 Boston
Synageva BioPharma Corp Receives $12,000,000 Series F Financing Round 10/21/09 Boston
Synageva Finishes $45M Round 10/20/09 Boston
Synageva BioPharma Corp Lands $12,000,000 New Financing Round 10/20/09 Boston
Direct Flow Medical Lands $40,000,000 Series C Financing 10/04/09 San Francisco
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
Presidio Pharmaceuticals Secures $27,000,000 Series B Financing 07/10/09 San Francisco
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News 06/17/09 Boston
Interlace Sews Up $20.5M Series C Round 06/15/09 Boston
Interlace Medical Inc Obtains $20,500,000 Series C Funding Round 06/15/09 Boston
Visiogen, Inc. Garners $40,000,000 New Funding Round 04/27/09 San Diego
Relypsa Lands $10,000,000 Series A Financing Round 03/11/09 San Francisco
ReShape Medical Garners $20,000,000 Series B Round 02/03/09 San Diego
Biogen Idec Makes Controversial Tysabri Decision, Boston Scientific Explains Stock Sales, Charles River Heads to China, & More Boston-Area Life Sciences News 10/16/08 Boston
Concert Pharmaceuticals, Flush With Well-Timed Venture Round, Aims for Hot Flashes, HIV 10/14/08 Boston
Aesthetic Sciences Corporation Secures $3,000,000 New Round 09/30/08 San Francisco
Concert Pharmaceuticals Enters Clinical Trials with Drug for Hot Flashes 09/25/08 Boston
GluMetrics, Inc. Obtains $20,000,080 Series C Round 08/10/08 San Diego
Pearl Therapeutics Receives $18,000,000 Series A Financing Round 07/03/08 San Francisco
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News 05/07/08 Boston
Mascoma Teams with GM, Moldflow Melds with Autodesk, Concert Scores Some Heavy-Duty Cash, & More Deals News 05/05/08 Boston
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals 05/01/08 Boston
Page 2 of 3 « previous page · next page »